Better Science, Better Lives: Women's Health Research at Yale is Working for You
Across the country, it’s becoming clearer every day: We must study the health of women. We must study the influence of sex-and-gender differences on health. And it’s time for all aspects of medical research and practice to embrace this change.
Yale Study Identifies How Cancer Drug Inhibits DNA Repair in Cancer Cells
Yale Cancer Center researchers have found that a cancer drug thought to be of limited use possesses an unforeseen property. It is able to stop certain cancer cells from repairing their DNA in order to survive. The study suggests that combining this drug, cediranib, with other agents could potentially deliver a lethal blow in cancer that uses a specific process to create DNA repair cells.
Antiretroviral Therapy Crucial in Preventing non-Hodgkin Lymphoma, YSPH Study Reinforces
A research team led by the Yale School of Public Health has found that for people living with HIV/AIDS, both recent immunosuppression and prolonged HIV viremia play important and independent roles in the development of non-Hodgkin lymphoma.
Breaking it Down: How the Chemistry of Digestion is Uncovering Sex-Specific Causes of Colon Cancer
A new technology called metabolomics allows researchers to explore the small chemicals formed and used during digestion as a window into the formation of diseases such as colon cancer, seeking early warning signs and potent tactics for prevention.
Study Shows Cigarillo Flavors Enhanced by High-intensity Sweeteners
In a new study, Yale researchers found that popular brands of cigarillos are flavored with high-intensity sweeteners, potentially reducing the aversive sensation of smoking and making cigarillos more palatable. The concern is that these sweeteners encourage young people to smoke cigarillos.
Yale Cancer Researchers Suggest New Treatment for Rare Inherited Cancer
Studying two rare inherited cancer syndromes, Yale Cancer Center (YCC) scientists have found the cancers are driven by a breakdown in how cells repair their DNA. The discovery, published today in Nature Genetics, suggests a promising strategy for treatment with drugs recently approved for other forms of cancer.
Experts Convene to Discuss Improving Reproducible Research Practices for Schools of Public Health
It is estimated that more than $200 billion is spent on biomedical research every year. The return on that investment is too low, agree a group of experts who gathered at the Yale School of Public Health to discuss reproducibility and transparency in research last week.
Vasilis Vasiliou designated the Bliss Professor of Epidemiology
Vasilis Vasiliou, newly designated as the Susan Dwight Bliss Professor of Epidemiology, focuses his research on investigating the mechanisms of cellular responses to environmental stress and gene-environment interactions involved in a number of diseases, including alcohol-induced liver disease and various forms of cancer such as colon and pancreatic cancer, gout, obesity and diabetes.
Building Research Networks and Friendships, Fulbright Fellow Looks Forward to Future Collaborations
Salmaan Inayat-Hussain, Ph.D., studies the health risks associated with chemicals used in petroleum and natural gas. He is now on a six-month Fulbright Malaysian Professional Exchange Program Fellowship at the Yale School of Public Health.
Can Digestive Chemistry Uncover Sex-Specific Causes of Colon Cancer?
Dr. Caroline Helen Johnson received this year’s Wendy U. and Thomas C. Naratil Pioneer Award and co-funding from the Yale Cancer Center to explore hormones and environmental factors related to metabolite production (such as sugars and amino acids) and beneficial bacteria that live in the colon as possible sources of gender difference.
Women’s Health Research at Yale funds studies on colon cancer, infections in pregnancy, and domestic violence
“Through our competitive peer review process, these three studies stood out as extremely promising opportunities to improve and even save lives,” said Dr. Carolyn M. Mazure, director of WHRY. “With these new grants, we continue to expand a broad scope of existing work to focus on questions vital to the health and well-being of millions of women, men, and children.”
Yale prof raises concerns about potential health hazards of recreational marijuana
NEW HAVEN >> Recreational marijuana use has been approved in Massachusetts starting in 2018, and there is an effort for it to be legalized in Connecticut, but a Yale School of Public Health professor is warning of cannabis’ potential hazards.
HBO Documentary on Alcoholism Previewed at Yale School of Public Health
Alcohol is woven into the fabric of American life. It is used to socialize, celebrate and relax. But for many, alcohol use comes with a steep price. The misuse of alcohol and drugs cost the United States $442 billion a year and close to 21 million people in the live with a substance use disorder.
Fracking Linked to Cancer-Causing Chemicals, New YSPH Study Finds
An expansive new analysis by Yale School of Public Health researchers confirms that numerous carcinogens involved in the controversial practice of hydraulic fracturing have the potential to contaminate air and water in nearby communities.
YSPH Study of Environmental Contaminants Associated with Fracking Underway in Ohio
A team of Yale School of Public Health scientists has launched the Ohio Water and Air Quality Study in Belmont County, Ohio. The scientists will collect and analyze water and air samples this summer as well as administer health questionnaires to 100 residents in communities with unconventional natural gas development. The researchers will investigate the potential for exposure to environmental pollutants and whether any health problems have resulted.